Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.
Swaplebar
Try 5mins 45 seconds
https://www.proactiveinvestors.co.uk/companies/news/927849/open-orphan-plc-proactive-one2one-virtual-conference-927849.html
Bronxville - Could you please highlight which comments were of racial undertones and by what posters, i have looked and couldn't see anything remotely racist.
You only have to look at the advances wearables are making in the monitering of glucose in bloodstream for diabetics, the tech is moving at warpspeed.
To get regulatory approval and planning permissions and the build time to construct a purpose built quarantine unit will be in the region of 18 months to 2 years, plus at current estimates the cost of £40 million. Also where do you think Oxford will get the staff with decades of experience running challenge trials.
I know CF has previously stated on a number of occasions that Invesco were happy to hold, but sometimes circumstances change.
Bear - when the RNS landed that stated OO and quotient had entered into an agreement over antibody testing on 11th May the sp stood at 12.4p, so has risen less than a penny in the 3 months since, so yeh no big deal.
Executive Summary
Codagenix, a company backed by Novartis, Merck and the Bill & Melinda Gates Foundation, has tied up with India’s Serum Institute to develop a vaccine against SARS-CoV-2, joining a heated race against the dreaded COVID-19 outbreak.
hTTps://scrip.pharmaintelligence.informa.com/SC141666/CodagenixSerum-Join-Fray-To-Develop-SARSCoV2-Vaccine
Maurice Treacy talks about Genomic data and it's value to open orphan, starts to cover it in depth from about 13 minutes in.
hTTps://www.youtube.com/watch?v=XrT6SBVa5F0
Swapleber - The Israel company Biondvax which also has a universal flu vaccine is listed on Nasdaq with mkt cap $250 million usd, they are all ready in phase 3 and due to report in 6 months time. It appears though that they are a 0ne trick pony with nothing else in their stable.
Latest CF interview, i believe recorded yesterday;
hTTps://www.youtube.com/watch?v=SkzUP8n_d08
come on guys , knock it on the head please.
Rudey - bear in mind that CF stated that the profit on the challenge studies was circa 40%, not sure if that is gross or net though.
Luckyball - Might be worth letting Cathal know, contact, Cathal.Friel@openorphan.com
Can i ask you why you think it would be ?
malteaser - looks like Youregene are well behind everyone else, it's a antigen test is it not ?
Potential Mossie vaccine would no doubt have the Bill and Melinda Gates Foundation and the Open Philanthropy Project interested..
Last contract we signed we didn't know who it was with either except that it was a US Biotech company, we did get info on contract value though. I assume that this time there was no info on contract value as they are signing multipile contracts which may have differing terms.
barwickman - has obviously sold or he needs to go to specsavers.
Probably because it is commercially sensitive info, especially when they are signing many of these contracts with various major pharma companies, terms may differ !
Northseatiger1 - since when has Venn been one of the top pharmaceutical companies in the world.